Your browser doesn't support javascript.
loading
Clinical Features and Pathology of PLA2R and THSD7A-Associated Membranous Nephropathy: A Single-Center Study from China.
Pan, Yan; Chen, Wei Dong; Liu, Lei; Yang, Huijuan; Chang, Baochao; Cui, Caixia.
Afiliação
  • Pan Y; Department of Nephrology, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, People's Republic of China.
  • Chen WD; Department of Nephrology, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, People's Republic of China.
  • Liu L; Department of Nephrology, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, People's Republic of China.
  • Yang H; Department of Nephrology, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, People's Republic of China.
  • Chang B; Department of Nephrology, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, People's Republic of China.
  • Cui C; Department of Nephrology, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, People's Republic of China.
Immunotargets Ther ; 13: 385-398, 2024.
Article em En | MEDLINE | ID: mdl-39081263
ABSTRACT

Objective:

Serum-specific antibodies as a non-invasive means to effectively diagnose idiopathic membranous nephropathy and assess clinicopathology.

Methods:

Immunofluorescence of anti-PLA2R and THSD7A antibodies and kidney tissue PLA2R, THSD7A and IgG4 expression in IMN and non-IMN (2020-2021) was detected to assess the efficacy of diagnosing IMN. IMN patients were divided into two groups, anti-PLA2R antibody positive (161 cases) and negative (26 cases), and two groups, kidney tissue PLA2R (40 cases) and PLA2R+THSD7A (6 cases), to compare the clinical and pathological features, and to carry out a prognostic analysis of THSD7A-positive patients, with a focus on correlation with malignancy.

Results:

The positive rate of anti-PLA2R antibodies was significantly higher in IMN (P<0.05); anti-PLA2R antibodies, kidney tissue PLA2R and IgG4 and THSD7A had some diagnostic value. Anti-PLA2R antibodies correlated with proteinuria levels in IMN patients, and their levels were negatively correlated with blood albumin (r=-0.146, P=0.042); correlated with pathological stage and C3 and IgG4 immunodeposition; there was no significant difference in clinical pathology between kidney tissue THSD7A+PLA2R positive compared to kidney tissue PLA2R positive patients, but the probability of achieving complete remission was low and time longer, and no malignancy events were detected during follow-up.

Conclusion:

Anti-PLA2R antibodies, kidney tissue PLA2R, THSD7A and IgG4 have high diagnostic efficacy for IMN; anti-PLA2R antibodies can be used as diagnostic markers to assist in the assessment of clinical and pathological features; co-expression of kidney tissue PLA2R and THSD7A is not significantly different from kidney tissue PLA2R in assessing the clinical features, pathological manifestations and prognosis, but requires long-term. However, long-term follow-up is needed to monitor the potential risk, and a larger multicentre study with long-term follow-up is expected to be conducted to comprehensively assess IMN characteristics.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Immunotargets Ther Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Immunotargets Ther Ano de publicação: 2024 Tipo de documento: Article